Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.
Pauwels
S
S
Department of Nuclear Medicine, University of Louvain Medical School, Brussels, Belgium.
Leners
N
N
Fiasse
R
R
Jamar
F
F
D003952:Diagnostic Imaging; D005500:Follow-Up Studies; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000378:metabolism; D006801:Humans; D007089:Image Enhancement; D007205:Indium Radioisotopes; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000556:secondary; D015282:Octreotide / Q000031:analogs & derivatives* / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000378:metabolism; D004369:Pentetic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D011446:Prospective Studies; D017481:Receptors, Somatostatin / Q000378:metabolism; D015899:Tomography, Emission-Computed, Single-Photon
D007205:Indium Radioisotopes; D017481:Receptors, Somatostatin; C071632:SDZ 215-811; D004369:Pentetic Acid; D015282:Octreotide